Follow- up of neonates with hypoxic ischemic encephalopathy using distortion product otoacoustic emissions hearing test

张峥,迟放鲁,陈超
DOI: https://doi.org/10.3321/j.issn:1673-8225.2003.07.038
2003-01-01
Abstract:Aim. To investigate the feasibility and clinical significance of hearing test using distortion product otoacoustic emissions (DPOAE) when it is applied to the follow-up of neonates with hypoxic ischemic encephalopathy (HIE). Methods. 35 healthy newborns and 45 cases of HIE neonates were tested by DPOAE before their discharge of the hospital. All HIE neonates were tested with DPOAE 1 and 6 months later. Those who failed in 2 tests with DPOAE were tested with brain-stem response (ABR). The results were compared with those of 35 healthy neonates using prospective cohort. Result. The presence of DPOAE in HIE neonates was 67% in the first test. In the follow-up one and six months later, the presence was 73% and 79%, respectively. The presence of DPOAE at 2 000Hz in the first month and at both 2 000 Hz and 4 000 Hz in the 6 month were higher than that in the first test. Two HIE neonates were diagnosed as hearing loss by ABR. Conclusion. The DPOAE test has been found to be an efficient way in the follow-up of HIE neonates who are considered as high risk candidates for hearing loss. It is possible that the hearing of HIE neonates could be improved at 2 000 Hz and 4 000 Hz.
What problem does this paper attempt to address?